retatrutide legal Delivers Significant Hemoglobin A1C Reduction, Weight Loss in Phase 3 Type 2 Diabetes Trial How To Get Retatrutide with

While the first GLP-1 was approved by the FDA more than 20 years ago, to treat Type 2 diabetes, the use of these drugs took off in 2021 when Novo Nordisk received approval for a semaglutide drug to treat obesity, with the brand name Wegovy

PubMed, de Luis, Daniel Antonio, Hilda F

GLP1s may offer midlife women other benefits besides weight loss

"Upon achieving your target weight, our team will collaborate with you to determine the optimal treatment strategy for transitioning to a weight maintenance phase

Recent reports suggest that as of 2022, 12% of adults in the United States have taken a GLP-1 agonist for weight loss at some point